Table 1.
High risk | Medium risk | Low risk or no risk |
---|---|---|
Cyclophosphamide | Cisplatin | Methotrexate |
Busulfan | Adriamycin | 5-Fluorouracil |
Melphalan | Paclitaxel (needs more studies) | Actinomycin D |
Procarbazine | Bleomycin | |
Nitrogen mustard | Vincristine | |
Chlorambucil |